文献速递临床微生物质量管理与危急值分子诊断

临床病理学的现代炼金术:将微生物实验室运营产出转化为金

The modern alchemy of clinical pathology: turning the output of microbiology laboratory operations into gold.
PubMed 文献 · J Clin Microbiol · 2024-03-20

本文综述了临床微生物实验室产生的高质量数据经提取、清洗、分析和验证后,可用于支持实验室运营、了解本地流行病学、制定医院政策和公共卫生监测。作者以抗菌药物敏感性试验(AST)为例,阐述下一代数据分析的潜在应用,包括持续监测商业AST系统、分析联合MIC分布及链接微生物数据与临床元数据。实现这一愿景需多方持续协作。

要点

  • 微生物实验室数据经规范分析流程可拓展用于运营支持、流行病学分析和公共卫生监测。
  • 通过比较MIC分布随时间的变化,可触发商业AST系统的重新验证。
  • 将微生物数据与临床元数据链接,有助于评估AST数据的临床有效性并指导治疗政策。

核心结论

  • 临床微生物实验室产生的高质量数据经适当提取、清洗、分析和验证后,可服务于实验室运营、本地流行病学、医院政策和公共卫生监测等多重目的。

研究设计与样本

  • 本文为综述,以抗菌药物敏感性试验(AST)为核心活动,阐述下一代数据分析的潜在应用。

主要发现

  • 持续监测商业AST系统可通过比较随时间变化的最低抑菌浓度(MIC)分布,在检测到统计学显著差异时触发重新验证。
  • 对联合MIC分布进行时间分析有助于理解多重耐药菌的检测性能。
  • 将微生物数据与临床元数据链接可深入了解AST数据的临床有效性并指导治疗政策。

临床怎么用

  • 利用常规数据流构建稳健且经过验证的分析引擎,以支持实验室运营和临床决策。
  • 通过MIC分布的时间比较,对商业AST系统进行持续性能监测。
  • 链接微生物数据与临床元数据,评估AST数据的临床有效性并辅助制定治疗政策。

局限性

  • 实现这一愿景面临诸多挑战,需要医院领导、微生物学家、临床医生、抗菌药物管理团队、数据科学家和监管机构的持续协作与倡导。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The clinical microbiology laboratory generates a huge amount of high-quality data that play a vital role in clinical care. With proper extraction, cleaning, analysis, and validation pipelines, these data can serve multiple other purposes that include supporting laboratory operations, understanding local epidemiology, informing hospital-specific policies, and public health surveillance. In this review, I use one of the core activities of the microbiology laboratory, antimicrobial susceptibility testing (AST), to illustrate several potential applications of next-generation data analytics. The first involves continuous monitoring of commercial AST systems using comparisons of minimum inhibitory concentration (MIC) distributions over time to trigger re-verification when statistically significant differences are detected. An extension of this is temporal analysis of joint MIC distributions to understand performance for multidrug-resistant organisms. More sophisticated analyses involve linking microbiologic data to clinical metadata to gain insight into the clinical validity of AST data and to inform treatment policies. The elements of a robust, validated analysis engine using routine data streams already exist, but numerous challenges must be overcome to make it a reality. Most importantly, it will require the sustained collaboration and advocacy of hospital leadership, microbiologists, clinicians, antimicrobial stewardship, data scientists, and regulatory agencies. Though no small feat, achieving this vision would provide an important resource for microbiology laboratories facing a rapidly evolving practice landscape and further cement its role as an integral part of a learning health system.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Kanjilal S. The modern alchemy of clinical pathology: turning the output of microbiology laboratory operations into gold. J Clin Microbiol. 2024. PMID: 38506516. doi:10.1128/jcm.01709-22

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。